- Home
- CPTN vs IOBT Comparison
CPTN vs IOBT Comparison
Compare CPTN & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPTN
- IOBT
- Stock Information
- Founded
- CPTN 2016
- IOBT 2014
- Country
- CPTN United States
- IOBT Denmark
- Employees
- CPTN N/A
- IOBT N/A
- Industry
- CPTN Industrial Machinery/Components
- IOBT Biotechnology: Pharmaceutical Preparations
- Sector
- CPTN Industrials
- IOBT Health Care
- Exchange
- CPTN Nasdaq
- IOBT Nasdaq
- Market Cap
- CPTN 51.4M
- IOBT 56.7M
- IPO Year
- CPTN N/A
- IOBT 2021
- Fundamental
- Price
- CPTN $3.20
- IOBT $0.77
- Analyst Decision
- CPTN Hold
- IOBT Strong Buy
- Analyst Count
- CPTN 2
- IOBT 3
- Target Price
- CPTN $2.50
- IOBT $9.33
- AVG Volume (30 Days)
- CPTN 73.7K
- IOBT 629.7K
- Earning Date
- CPTN 11-07-2024
- IOBT 11-12-2024
- Dividend Yield
- CPTN N/A
- IOBT N/A
- EPS Growth
- CPTN N/A
- IOBT N/A
- EPS
- CPTN N/A
- IOBT N/A
- Revenue
- CPTN $17,872,000.00
- IOBT N/A
- Revenue This Year
- CPTN $43.75
- IOBT N/A
- Revenue Next Year
- CPTN $41.30
- IOBT N/A
- P/E Ratio
- CPTN N/A
- IOBT N/A
- Revenue Growth
- CPTN 84.59
- IOBT N/A
- 52 Week Low
- CPTN $2.38
- IOBT $0.66
- 52 Week High
- CPTN $3.81
- IOBT $2.10
- Technical
- Relative Strength Index (RSI)
- CPTN 61.66
- IOBT 39.04
- Support Level
- CPTN $3.10
- IOBT $0.75
- Resistance Level
- CPTN $3.22
- IOBT $0.84
- Average True Range (ATR)
- CPTN 0.03
- IOBT 0.07
- MACD
- CPTN 0.00
- IOBT 0.00
- Stochastic Oscillator
- CPTN 65.27
- IOBT 13.79
About CPTN Cepton Inc.
Cepton Inc provides lidar-based solutions for a range of markets such as automotive, smart cities, smart spaces and smart industrial applications. The company's patented MMT-based lidar technology enables reliable, scalable and cost-effective solutions that deliver long range, high resolution 3D perception for smart applications.
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.